AtriCure to Participate at Upcoming Investor Conferences
April 27 2020 - 4:02PM
Business Wire
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical
treatments for atrial fibrillation (Afib) and left atrial appendage
(LAA) management, today announced that the company will be
participating in two upcoming investor conferences.
AtriCure will be participating in the Bank of America Securities
2020 Health Care Conference, scheduled to be held virtually May
12-14, 2020. AtriCure’s management is scheduled to present on
Tuesday, May 12, 2020, at 3:00 p.m. Eastern Time. Interested
parties may access a live audio webcast of the presentation by
visiting the “Investors” section of the company’s website at
https://ir.atricure.com.
AtriCure management will be participating in 1x1 meetings at the
UBS Global Healthcare Conference, scheduled to be held virtually
May 18-20, 2020.
About AtriCure
AtriCure, Inc. provides innovative technologies for the
treatment of Afib and related conditions. Afib affects more than 33
million people worldwide. Electrophysiologists and cardiothoracic
surgeons around the globe use AtriCure technologies for the
treatment of Afib and reduction of Afib related complications.
AtriCure’s Isolator® Synergy™ Ablation System is the first and only
medical device to receive FDA approval for the treatment of
persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage
Exclusion System products are the most widely sold LAA management
devices worldwide. For more information, visit AtriCure.com or
follow us on Twitter @AtriCure.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200427005803/en/
Andy Wade AtriCure, Inc. Senior Vice President and Chief
Financial Officer (513) 755-4564 awade@atricure.com
Lynn Pieper Lewis Gilmartin Group Investor Relations (415)
937-5402 lynn@gilmartinir.com
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Aug 2024 to Sep 2024
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Sep 2023 to Sep 2024